Ignite Creation Date:
2024-05-06 @ 8:38 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02788240
Status:
TERMINATED
Last Update Posted:
2018-02-06
First Post:
2016-03-22
Brief Title:
To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
Sponsor:
Institute of Liver and Biliary Sciences India
Organization:
Institute of Liver and Biliary Sciences India
Study Overview
Official Title:
To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase - A Randomized Controlled Study
Status:
TERMINATED
Status Verified Date:
2018-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
All consecutive ACLF Acute on Chronic Liver failure patients presenting to the institute of liver and biliary sciences irrespective of the etiology who have survived the acute phase ie 90 days of onset of the acute on chronic liver failure and who are willing to participate in the study would be enrolled After performing baseline biochemical tests patients will undergo transjugular liver biopsy TJLB HVPG Hepatic Venous Pressure Gradient Circulating CD34 cells Bone marrow aspiration and biopsy Histopathological and immunohistochemical examination will be done
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None